OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 27 citing articles:

Sodium butyrate ameliorates diabetic retinopathy in mice via the regulation of gut microbiota and related short-chain fatty acids
Yinhua Huang, Zhijie Wang, Bo Ye, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 34

Chronic kidney disease and gut microbiota
Siamak Amini Khiabani, Mohammad Asgharzadeh, Hossein Samadi Kafil
Heliyon (2023) Vol. 9, Iss. 8, pp. e18991-e18991
Open Access | Times Cited: 31

The roles of gut microbiota and its metabolites in diabetic nephropathy
Hui Zhao, Cheng-E Yang, Tian Liu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 26

Effects of microbial-derived biotics (meta/pharma/post-biotics) on the modulation of gut microbiome and metabolome; general aspects and emerging trends
Alireza Sadeghi, Maryam Ebrahimi, Mohammad Saeed Kharazmi, et al.
Food Chemistry (2023) Vol. 411, pp. 135478-135478
Closed Access | Times Cited: 24

Gut microbiota and its metabolites – molecular mechanisms and management strategies in diabetic kidney disease
Zi‐Hui Mao, Zhong‐Xiuzi Gao, Dongwei Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24

Causal relationship between gut microbiota and diabetic nephropathy: a two-sample Mendelian randomization study
Shuxiang Yan, Hua Wang, Baiyu Feng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11

Enriched Aptamer Libraries in Fluorescence-Based Assays for Rikenella microfusus-Specific Gut Microbiome Analyses
Yiting Zhang, Xing Hu, Grigory Bolotnikov, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2266-2266
Open Access | Times Cited: 17

Predicting the role of the human gut microbiome in type 1 diabetes using machine-learning methods
Xiaowei Liu, Hanlin Li, Cai-Yi Ma, et al.
Briefings in Functional Genomics (2024) Vol. 23, Iss. 4, pp. 464-474
Closed Access | Times Cited: 7

The Sanbi Decoction alleviates intervertebral disc degeneration in rats through intestinal flora and serum metabolic homeostasis modulation
Nan Wang, Shuang Chen, Yimin Xie, et al.
Phytomedicine (2024) Vol. 127, pp. 155480-155480
Closed Access | Times Cited: 7

Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota
Xiaqing Wu, Lei Zhao, Yanlong Zhao, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 423-435
Open Access | Times Cited: 6

Identification of the main flavonoids of Abelmoschus manihot (L.) medik and their metabolites in the treatment of diabetic nephropathy
Zhipeng Diao, Hongmei Yu, Yapeng Wu, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 5

Meta-analysis of postbiotics on evaluating health benefits and mechanisms
Kaliyan Barathikannan, Ramachandran Chelliah, Host Antony David, et al.
Elsevier eBooks (2025), pp. 351-376
Closed Access

Leptin pathway is a crucial target for anthocyanins to protect against metabolic syndrome
M. Liu, Siyu Li, Meiyi Guan, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-16
Closed Access | Times Cited: 4

Voluntary wheel running ameliorated the deleterious effects of high-fat diet on glucose metabolism, gut microbiota and microbial-associated metabolites
Ling Zhang, Wenyu Zou, Yongyan Hu, et al.
Deleted Journal (2024) Vol. 13, Iss. 3, pp. 1672-1684
Open Access | Times Cited: 3

Intestinal flora and bile acid interactions impact the progression of diabetic kidney disease
Jia Xu, Nan Wang, Li Yang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3

Metabolomic profiles in serum and urine uncover novel biomarkers in children with nephrotic syndrome
Lidan Hu, Li Lin, Guoping Huang, et al.
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 7
Closed Access | Times Cited: 7

Gut microbiota microbial metabolites in diabetic nephropathy patients: far to go
Jianxiu Yu, Xin Chen, Su-Gang Zang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2

Geniposide ameliorates diabetic nephropathy in type 2 diabetic mice by targeting AGEs-RAGE-dependent inflammatory pathway
Dina Zhu, Ying Ni, Chao Chen, et al.
Phytomedicine (2024) Vol. 135, pp. 156046-156046
Closed Access | Times Cited: 2

Impact of Microplastic Exposure on Blood Glucose Levels and Gut Microbiota: Differential Effects under Normal or High-Fat Diet Conditions
Manjin Xu, Huixia Niu, Lizhi Wu, et al.
Metabolites (2024) Vol. 14, Iss. 9, pp. 504-504
Open Access | Times Cited: 2

Single-Cell Transcriptional Landscape Reveals the Regulatory Network and Its Heterogeneity of Renal Mitochondrial Damages in Diabetic Kidney Disease
Chenhua Wu, Yuhui Song, Yihong Yu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13502-13502
Open Access | Times Cited: 5

Integration of systematic review, lipidomics with experiment verification reveals abnormal sphingolipids facilitate diabetic retinopathy by inducing oxidative stress on RMECs
Zhenshuang Yuan, Yue Tian, Cong Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2023) Vol. 1868, Iss. 11, pp. 159382-159382
Closed Access | Times Cited: 4

Page 1 - Next Page

Scroll to top